Pure Global AI
NCT05982171Not yet recruiting

Transcutaneous Spinal Cord Stimulation to Promote Walking Recovery After Spinal Cord Injury

Craig HospitalClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Spinal Cord Injuries
Drug/Device/Intervention
Exo + TSCS
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Craig Hospital
Timeline & enrollment
Phase
N/A
Start date
Sep 15, 2023
End date
Sep 15, 2024
Enrollment
30 participants
Primary outcome

Change in score on Walking Index for SCI (WISCI) II

Summary

The goal of this clinical trial is to investigate the effects of transcutaneous spinal cord
 stimulation (TSCS) combined with exoskeleton training, as compared to exoskeleton training
 alone to improve motor function in individuals with incomplete spinal cord injury who are 12
 months or less post-injury. Participants will be randomly assigned to a treatment group
 (exoskeleton training with TSCS, or exoskeleton training without TSCS). Participants in both
 groups will undergo a baseline evaluation, then take part in 24, 1-hour training sessions at
 Craig Hospital. After the 24 sessions have concluded, participants will undergo a
 post-treatment evaluation as well as a follow-up evaluation four weeks after training is
 completed. Researchers will compare the two groups by evaluating the following areas:
 
 - walking ability and speed
 
 - lower extremity strength, activation, and spasticity
 
 - trunk control
 
 - bowel and bladder function

ICD-10 classifications
Sequelae of injury of spinal cordOther and unspecified injuries of thoracic spinal cordOther and unspecified injuries of cervical spinal cordOther injury of lumbar spinal cordInjury of spinal cord, level unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05982171
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05982171 through Pure Global AI's free database. This phase not specified trial is sponsored by Craig Hospital and is currently Not yet recruiting. The study focuses on Spinal Cord Injuries. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.